India's Ajanta Pharma hits record high after Q1 profit climb
** Shares of Ajanta Pharma AJPH.NS climb as much as 6.7%
to a record high of 2,579.90 rupees
** Stock set for ninth straight session of gain
** Drugmaker's Q1 consol profit after tax rose 18% Y/Y; rev
grew 12% Y/Y
** Mean rating of nine analysts is "buy"; median PT is 2,400
rupees - LSEG data
** Stock up 24% YTD after gaining 73% in 2023
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility